Biotech ETF (CANC) Hits New 52-Week High
Tema Oncology ETF CANC is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has surged 72.8% from its 52-week low price of $26.24 per share.Are more gains in store for this ETF? Let us take a quick look at the fund and the near-term outlook on it to get a be…
Tema Oncology ETF CANC is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has surged 72.8% from its 52-week low price of $26.24 per share.Are more gains in store for this ETF? Let us take a quick look at the fund and the near-term outlook on it to get a be…
What's Your Reaction?
